Innovative DNA Plasmid Therapy NWRD06 Targets HCC After Surgery
Patients with hepatocellular carcinoma (HCC) now have a potential new treatment option following curative surgery. A novel DNA plasmid therapy […]
Patients with hepatocellular carcinoma (HCC) now have a potential new treatment option following curative surgery. A novel DNA plasmid therapy […]
On January 10, 2026, a new development in the monitoring of generalized myasthenia gravis (gMG) through advanced digital technology was
A new clinical trial is set to explore the efficacy of the ActiTENS Mini, a transcutaneous electrical nerve stimulation device,
Beijing Tiantan Hospital has announced a promising clinical trial exploring advancements in stroke treatment for ischemic stroke patients with medium
A new clinical trial aims to evaluate the effectiveness of a hearing rehabilitation program targeting elderly patients with communication disorders.
On January 12, 2026, an update emerged for a clinical trial investigating pain levels associated with traditional versus ultrasound-guided intrauterine
A newly announced clinical trial aims to evaluate the effectiveness and safety of linaprazan glurate in maintaining healing for patients
On January 12, 2026, a clinical trial involving a medical device that has not yet been approved or cleared by
Published Date: January 10, 2026 A groundbreaking treatment known as AmblyoFix is now under evaluation for its potential to treat
A new clinical trial, sponsored by the University of Illinois at Urbana-Champaign and other collaborators, aims to explore a method